RNAV8 BIO

Website

RNAV8 BIO, INC.

42 Investors
Biotechnology
LAGUNA NIGUEL, CA

RNAV8 Bio, Inc. is an innovative biotechnology company dedicated to enhancing the efficacy of mRNA therapeutics. By harnessing advanced technologies like machine learning and artificial intelligence, RNAV8 aims to revolutionize the field of mRNA-based drug development for a wide array of diseases.

Products & Team

mRNA Engineering and Design Platform

mRNA TherapeuticsSeed

The mRNA engineering and design platform developed by RNAV8 utilizes machine learning and artificial intelligence to optimize mRNA functions. This platform is designed to improve the expression levels of mRNA, thus enhancing the potency and specificity of mRNA-based therapeutics.

Value Proposition

RNAV8's platform addresses the challenges of optimizing mRNA drug candidates, thereby increasing their therapeutic potential and enabling the treatment of more diseases.

Pain Points

Challenges in optimizing mRNA therapeutics and increasing their effectiveness in treating various diseases.

Integration of rational design techniquesUse of advanced machine learning algorithmsCapability to tailor mRNA functions for various applicationsEnhanced mRNA expression compared to conventional approaches

Devan Shah

Company Signatory
Chief Executive Officerat RNAV8 BIO, INC.
Joined RNAV8 BIO, INC.
March 2025
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
LAGUNA NIGUEL, CA
Primary headquarters

Funding History

Total Raised:
$2.0M
E

Option to Acquire Offering

May 2022
$3.0M
Target
Progress
67%
Raised
$2.0M
Target
$3.0M
#000196074525000002